Literature DB >> 12673488

Functional outcome following low anterior resection with total mesorectal excision in the elderly.

Pei Ho1, Wai Lun Law, See Ching Chan, Chi Kee Lam, Kin Wah Chu.   

Abstract

BACKGROUND AND AIMS: Disturbance of bowel function is not uncommon following low anterior resection, but the effect of low anterior resection on the elderly has seldom been documented. This study investigated the functional outcome in elderly patients following low anterior resection for carcinoma of the rectum. PATIENTS AND METHODS: The study included 87 patients with carcinoma of middle and lower rectum who underwent curative low anterior resection with total mesorectal excision and remained alive without recurrence for at least 6 months following the resection or closure of stoma. Anorectal manometry and questionnaire survey of the patients' bowel function were performed during follow-up (median 24.1 months) to investigate the functional outcome after surgery.
RESULTS: The median number of bowel motions was 2.5 per day in both elderly and young patients. Complete continence was achieved in 71.3% of patients, with both elderly and young patients performing similarly. The most common symptoms were clustering of bowel motions and urgency, which occurred in 30.3% and 34.9% of patients respectively, regardless of age. Manometric findings were also similar between the elderly and their younger counterparts.
CONCLUSION: Bowel function and manometric findings following low anterior resection with total mesorectal excision in the elderly are not worse than in younger patients.

Entities:  

Mesh:

Year:  2002        PMID: 12673488     DOI: 10.1007/s00384-002-0442-3

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  15 in total

1.  Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.

Authors:  Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

2.  Outcomes of surgery for mid and distal rectal cancer in the elderly.

Authors:  Wai Lun Law; Hok Kwok Choi; Judy Wc Ho; Yee Man Lee; Chi Leung Seto
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.352

3.  Total mesorectal excision: what are we doing?

Authors:  David B Stewart; David W Dietz
Journal:  Clin Colon Rectal Surg       Date:  2007-08

4.  Significance of defect closure following transanal local full-thickness excision of rectal malignant tumors.

Authors:  Shingo Noura; Masayuki Ohue; Norikatsu Miyoshi; Masayoshi Yasui
Journal:  Mol Clin Oncol       Date:  2016-08-04

5.  Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm.

Authors:  Mario Morino; Marco Ettore Allaix; Mario Caldart; Gitana Scozzari; Alberto Arezzo
Journal:  Surg Endosc       Date:  2011-06-07       Impact factor: 4.584

Review 6.  Health-Related Quality of Life in Older Adults with Colorectal Cancer.

Authors:  Evan Lapinsky; Lillian C Man; Amy R MacKenzie
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075

7.  Transanal endoscopic microsurgery for rectal neoplasms. How I do it.

Authors:  Marco E Allaix; Alberto Arezzo; Simone Arolfo; Mario Caldart; Fabrizio Rebecchi; Mario Morino
Journal:  J Gastrointest Surg       Date:  2012-10-24       Impact factor: 3.452

8.  Transanal endoscopic microsurgery vs. laparoscopic total mesorectal excision for T2N0 rectal cancer.

Authors:  Marco Ettore Allaix; Alberto Arezzo; Giuseppe Giraudo; Mario Morino
Journal:  J Gastrointest Surg       Date:  2012-10-16       Impact factor: 3.452

Review 9.  Transanal endoscopic microsurgery.

Authors:  M Morino; A Arezzo; M E Allaix
Journal:  Tech Coloproctol       Date:  2013-01-12       Impact factor: 3.781

10.  Previous transanal endoscopic microsurgery for rectal cancer represents a risk factor for an increased abdominoperineal resection rate.

Authors:  Mario Morino; Marco Ettore Allaix; Simone Arolfo; Alberto Arezzo
Journal:  Surg Endosc       Date:  2013-03-12       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.